Gastrointestinal stromal tumours - an update for histopathologists

Gastrointestinal Stromal Tumors

(2012) Piotr Rutkowski et al.   Molecular Diagnosis & Therapy

Primary Extragastrointestinal Stromal Tumor of the Pleura: Report of a Unique Case With Genetic Confirmation

(2010) Kevin B. Long et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

BRAF Inhibitor Unveils Its Potential against Advanced Melanoma

(2010) Adina Vultur et al.   CANCER CELL

DOG1 and CD117 are the antibodies of choice in the diagnosis of gastrointestinal stromal tumours

(2010) Marco Novelli et al.   HISTOPATHOLOGY

Specificity of DOG1 (K9 clone) and protein kinase C theta (clone 27) as immunohistochemical markers of gastrointestinal stromal tumour

(2010) Newton A C S Wong et al.   HISTOPATHOLOGY

Strong expression of IGF1R in pediatric gastrointestinal stromal tumors without IGF1R genomic amplification

(2010) Katherine A. Janeway et al.   INTERNATIONAL JOURNAL OF CANCER

Carbonic anhydrase II. A novel biomarker for gastrointestinal stromal tumors

(2010) Seppo Parkkila et al.   MODERN PATHOLOGY

SDHB immunohistochemistry: a useful tool in the diagnosis of Carney–Stratakis and Carney triad gastrointestinal stromal tumors

(2010) José Gaal et al.   MODERN PATHOLOGY

DOG1 for the Diagnosis of Gastrointestinal Stromal Tumor (GIST): Comparison Between 2 Different Antibodies

(2010) Lisandro F. Lopes et al.   APPLIED IMMUNOHISTOCHEMISTRY & MOLECULAR MORPHOLOGY

KRAS Mutation Testing in Colorectal Cancer

(2009) Thomas P. Plesec et al.   ADVANCES IN ANATOMIC PATHOLOGY

BRAFMutation Status in Gastrointestinal Stromal Tumors

(2009) Isabelle Hostein et al.   AMERICAN JOURNAL OF CLINICAL PATHOLOGY

Ano1 is a selective marker of interstitial cells of Cajal in the human and mouse gastrointestinal tract

(2009) Pedro J. Gomez-Pinilla et al.   AMERICAN JOURNAL OF PHYSIOLOGY-GASTROINTESTINAL AND LIVER PHYSIOLOGY

A Novel Monoclonal Antibody Against DOG1 is a Sensitive and Specific Marker for Gastrointestinal Stromal Tumors

(2009) Inigo Espinosa et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Monoclonal Antibody DOG1.1 Shows Higher Sensitivity Than KIT in the Diagnosis of Gastrointestinal Stromal Tumors, Including Unusual Subtypes

(2009) Bernadette Liegl et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

DOG1 Antibody in the Differential Diagnosis of Gastrointestinal Stromal Tumors

(2009) Markku Miettinen et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Rhabdomyosarcomatous Differentiation in Gastrointestinal Stromal Tumors After Tyrosine Kinase Inhibitor Therapy

(2009) Bernadette Liegl et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Gastric Stromal Tumors in Carney Triad Are Different Clinically, Pathologically, and Behaviorally From Sporadic Gastric Gastrointestinal Stromal Tumors: Findings in 104 Cases

(2009) Lizhi Zhang et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Nilotinib in the treatment of advanced gastrointestinal stromal tumours resistant to both imatinib and sunitinib

(2009) M. Montemurro et al.   EUROPEAN JOURNAL OF CANCER

Extragastrointestinal stromal tumor arising in the rectovaginal septum: Report of an unusual case with literature review

(2009) Wenjing Zhang et al.   GYNECOLOGIC ONCOLOGY

Antigen retrieval and primary antibody type affect sensitivity but not specificity of CD117 immunohistochemistry

(2009) Newton A C S Wong et al.   HISTOPATHOLOGY

Insulin-like growth factor 1 receptor expression in wild-type GISTs: A potential novel therapeutic target

(2009) Maria A. Pantaleo et al.   INTERNATIONAL JOURNAL OF CANCER

V600E BRAF mutations are alternative early molecular events in a subset of KIT/PDGFRA wild-type gastrointestinal stromal tumours

(2009) A Agaimy et al.   JOURNAL OF CLINICAL PATHOLOGY

The triad of paragangliomas, gastric stromal tumours and pulmonary chondromas (Carney triad), and the dyad of paragangliomas and gastric stromal sarcomas (Carney-Stratakis syndrome): molecular genetics and clinical implications

(2009) C. A. Stratakis et al.   JOURNAL OF INTERNAL MEDICINE

KIT as a Therapeutic Target in Melanoma

(2009) Maria C. Garrido et al.   JOURNAL OF INVESTIGATIVE DERMATOLOGY

Adjuvant imatinib mesylate after resection of localised, primary gastrointestinal stromal tumour: a randomised, double-blind, placebo-controlled trial

(2009) Ronald P DeMatteo et al.   LANCET

Development and validation of a prognostic nomogram for recurrence-free survival after complete surgical resection of localised primary gastrointestinal stromal tumour: a retrospective analysis

(2009) Jason S Gold et al.   LANCET ONCOLOGY

An immunohistochemical procedure to detect patients with paraganglioma and phaeochromocytoma with germline SDHB, SDHC, or SDHD gene mutations: a retrospective and prospective analysis

(2009) Francien H van Nederveen et al.   LANCET ONCOLOGY

Gain-of-function PDGFRA mutations, earlier reported in gastrointestinal stromal tumors, are common in small intestinal inflammatory fibroid polyps. A study of 60 cases

(2009) Jerzy Lasota et al.   MODERN PATHOLOGY

Primary gastrointestinal stromal tumor of the liver: A case report

(2009) Xiao-Li Luo et al.   WORLD JOURNAL OF GASTROENTEROLOGY

Familial Gastrointestinal Stromal Tumors Caused by the Novel KIT Exon 17 Germline Mutation N822Y

(2008) Andreas Thalheimer et al.   AMERICAN JOURNAL OF SURGICAL PATHOLOGY

Insulin-like growth factor (IGF) 1 and 2 help to predict disease outcome in GIST patients

(2008) C. Braconi et al.   ANNALS OF ONCOLOGY

Which Is the Optimal Risk Stratification System for Surgically Treated Localized Primary GIST? Comparison of Three Contemporary Prognostic Criteria in 171 Tumors and a Proposal for a Modified Armed Forces Institute of Pathology Risk Criteria

(2008) Brian K. P. Goh et al.   ANNALS OF SURGICAL ONCOLOGY

Activity of Dasatinib, a Dual SRC/ABL Kinase Inhibitor, and IPI-504, a Heat Shock Protein 90 Inhibitor, against Gastrointestinal Stromal Tumor-Associated PDGFRAD842V Mutation

(2008) B. Dewaele et al.   CLINICAL CANCER RESEARCH

Molecular Characterization of Pediatric Gastrointestinal Stromal Tumors

(2008) N. P. Agaram et al.   CLINICAL CANCER RESEARCH

Follow-up of hepatic and peritoneal metastases of gastrointestinal tumors (GIST) under Imatinib therapy requires different criteria of radiological evaluation (size is not everything!!!)

(2008) Mylène Mabille et al.   EUROPEAN JOURNAL OF RADIOLOGY

Clinical significance of oncogenicKITandPDGFRAmutations in gastrointestinal stromal tumours

(2008) J Lasota et al.   HISTOPATHOLOGY

Risk stratification of patients diagnosed with gastrointestinal stromal tumor

(2008) Heikki Joensuu   HUMAN PATHOLOGY

Correlation of Kinase Genotype and Clinical Outcome in the North American Intergroup Phase III Trial of Imatinib Mesylate for Treatment of Advanced Gastrointestinal Stromal Tumor: CALGB 150105 Study by Cancer and Leukemia Group B and Southwest Oncology Group

(2008) Michael C. Heinrich et al.   JOURNAL OF CLINICAL ONCOLOGY

Primary and Secondary Kinase Genotypes Correlate With the Biological and Clinical Activity of Sunitinib in Imatinib-Resistant Gastrointestinal Stromal Tumor

(2008) Michael C. Heinrich et al.   JOURNAL OF CLINICAL ONCOLOGY

Inflammatory fibroid polyps harbour mutations in theplatelet-derived growth factor receptor alpha(PDGFRA)gene

(2008) H-U Schildhaus et al.   JOURNAL OF PATHOLOGY

Heterogeneity of kinase inhibitor resistance mechanisms in GIST

(2008) B Liegl et al.   JOURNAL OF PATHOLOGY

The Lessons of GIST--PET and PET/CT: A New Paradigm for Imaging

(2008) A. D. Van den Abbeele   ONCOLOGIST

Insulin-like growth factor 1 receptor is a potential therapeutic target for gastrointestinal stromal tumors

(2008) C. Tarn et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA